Three NYU faculty receive awards from Pew Charitable Trusts

June 24, 2014

Three NYU faculty have been selected to receive awards from the Pew Charitable Trusts, the Philadelphia-based non-profit announced today: Agnel Sfeir, an assistant professor at NYU Langone Medical Center; Ezequiel Arneodo, a postdoctoral research fellow at NYU Langone's Neuroscience Institute; and Yuriria Vázquez Zúñiga, a postdoctoral research fellow at NYU's Center for Neural Science.

Sfeir was selected as a member of the inaugural class of Pew-Stewart Scholars for Cancer Research. The Alexander and Margaret Stewart Trust and the Pew Charitable Trusts have launched this national initiative to support promising early career scientists whose research may accelerate discovery and advance progress to a cure for cancer.

"Cancer continues to take a terrible toll on human health worldwide, and creative approaches are vital for the development of novel therapies," said Rebecca W. Rimel, Pew's president and CEO. "We are delighted to partner with the Stewart Trust to expand our commitment to science and eagerly anticipate the discoveries these talented researchers will make to address these challenges."

Arneodo and Vázquez Zúñiga were selected as Pew Latin American Fellows in the Biomedical Sciences. The program, established in 1991, allows early-career scientists to train in top U.S. laboratories and to develop skills and connections that will help them become scientific leaders in their home countries.

"The promising researchers joining our community of fellows today will no doubt make an indelible impact on the international research landscape in years to come," Rimel noted. "They are committed, creative scientists who will add to the world's store of biomedical knowledge."

Arneodo, a native of Argentina, will conduct postdoctoral research in olfaction in the laboratory of Dmitry Rinberg, associate professor of neuroscience and physiology, at NYU Langone's Neuroscience Institute. Vázquez Zúñiga, a native of Mexico, will conduct postdoctoral research in neuroscience in the laboratory of Bijan Pesaran at NYU.
-end-


New York University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.